Clinical Trials Directory

Trials / Completed

CompletedNCT01066221

Comparative Study of Three Different Testing Mechanisms for Clostridium Difficile

Comparative Study of Enzyme Immunoassays:Techlab Toxins A&B, C Diff Quick Check for Glutamate Dehydrogenase (GDH);3 PCRs,and Cytotoxin Assay (CTA) for the Detection of Clostridium Difficile Toxin in Adult Stool Specimens

Status
Completed
Phase
Study type
Observational
Enrollment
470 (actual)
Sponsor
Hamilton Health Sciences Corporation · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to establish which of the following tests perform best in diagnosing clostridium difficile. PCR, Enzyme Immunoassays (EIA) and C. difficile cytotoxin assay (CTA).

Detailed description

This comparative study will be carried out in the hospital microbiology laboratory of a tertiary academic health center, St. Joseph's Healthcare (SJH) affiliated with McMaster University, Hamilton, ON on 500 individual stool samples from patients greater than 12 months of age to determine an efficacy of distinction between current gold standard and other methods of testing for Clostridium difficile. This study is required to find a faster test for diagnosis of CDI in order to facilitate prompt treatment and reduce the complications of CDI. Identification of infected cases will lead to the enforcement of infection control measures and thereby prevent spread to other susceptible children. This is turn will reduce costs, length of stay, morbidity, and mortality from CDI if instituted correctly.

Conditions

Timeline

Start date
2009-09-01
Primary completion
2010-03-01
Completion
2010-05-01
First posted
2010-02-10
Last updated
2011-07-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01066221. Inclusion in this directory is not an endorsement.